Xtalpi Holdings Stock price
Compare with Peer Group
Is Xtalpi Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Xtalpi Holdings Stock Analysis
Analyst Opinions
12 Analysts have issued a Xtalpi Holdings forecast:
Analyst Opinions
12 Analysts have issued a Xtalpi Holdings forecast:
Don't miss a Thing! We will send you all news about Xtalpi Holdings directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
XtalPi Holdings Ltd. provides drug and material science R&D solutions and services to global conglomerates and companies in the pharmaceutical and material science industries. The company is headquartered in Shenzhen, Guangdong and currently employs 1,054 full-time employees. The company went IPO on 2024-06-13. The firm mainly operates two businesses. Drug discovery solutions primarily encompass the development of early-stage lead compounds and investigational new drugs, providing research support for clinical trial initiation. Intelligent robotics solutions primarily include solid-state research and development services and automated chemical synthesis services. The firm conducts its business in the domestic and overseas markets.
| Head office | Cayman Islands |
| CEO | Mr. Chen |
| Employees | 1,254 |
| Website | www.xtalpi.com |


